This Spotlight Speaking Series is proudly presented by:
LifeSciences BC is pleased to feature STEMCELL Technologies Inc., UBC’s Sauder School of Business and AbCellera at our McCarthy Spotlight Speaking Event on “Leading Small Teams” on Thursday, September 22, 2016.
Event Topic: How to successfully manage and lead small teams or groups, whether in the context of a biotech start-up or within a larger life sciences organization.
UBC Sauder School of Business is one of the world’s leading academic business schools and provides a global business perspective at a dynamic crossroads of the international marketplace.
Sauder School of Business’ Organizational Behaviour and Human Resources (OBHR) Division focuses on many aspects of the employment relationship, including the culture of organizations, managing organizational change, the roles and skills of managers, the development of human resources, labour-management relations, and international human resource management.
Current OBHR programs include:
• PhD in Organizational Behaviour and Human Resources
• MBA, Master of Management, and Executive Education Modules in Organizational Behaviour and Human Resources
• BCom in Organizational Behaviour and Human Resources Management
Michael Daniels, Assistant Professor, Organizational Behaviour and Human Resources
Michael Daniels is an Assistant Professor of Organizational Behaviour and Human Resources at the Sauder School of Business, University of British Columbia. With a Ph.D. in Industrial-Organizational Psychology, Michael’s research applies psychological phenomena and principles to the workplace. His research program broadly focuses on the efficacy of leader characteristics (e.g., humility and narcissism) on individual and organizational outcomes. In addition, Michael and a co-author were recently awarded a grant from the Social Sciences and Humanities Research Council to study the nature and consequences of social shaming at work.
Prior to joining UBC, Michael was a visiting scholar at Singapore Management University and a Senior Research Associate at the Human Capital Leadership Institute, a think tank set up by the Singapore government to address issues related to leadership and talent in Asia. Michael’s work has been published in top-tier scholarly outlets such as Journal of Applied Psychology, Journal of Management, Leadership Quarterly, and Human Resource Management Review and has been cited in media outlets such as CBC.ca and HQ Asia.
AbCellera is a biotech company focused on the discovery and development of next-generation antibody therapies.
AbCellera has developed a disruptive and industry-leading technology for the discovery of antibodies from immunized animals and human patients. This platform is being used to advance a two-pronged business model that includes i) revenue generation through partnerships with biotechnology and pharma companies, and ii) advancing an internal pipeline of therapeutic antibodies for clinical development. Our long-term vision is to build an enduring Canadian biotechnology company that is the recognized industry leader in antibody therapeutics and immune profiling.
Carl Hansen, CEO
Carl Hansen is the founding CEO of AbCellera, a biotechnology company focussed on therapeutic antibody discovery, immune profiling, and immunotherapy. He holds an undergraduate degree in Engineering Physics and Mathematics (UBC, 2000), a PhD in Applied Physics and Biotechnology (Caltech, 2004), and completed his postdoctoral training with Leroy Hood at the Institute for Systems Biology in Seattle (2005). Dr. Hansen’s work is represented in more than 50 licensed patents and patent applications, and has contributed to commercial technologies used across fields of microfluidics, genomics, single cell analysis and immunology. In addition to leading AbCellera, Dr. Hansen is an associate professor in the Michael Smith Laboratories at UBC, where he maintains an active research group focused on technology development for cancer genomics and immunology. Dr. Hansen was a founding director of Precision Nanosystems, a high-growth Vancouver biotech developing best-in-class solutions for genetic medicines, and previously served as a member of the SAB for Fluidigm corporation (NASDAQ:FLDM). Carl is passionate about building a strong local biotech community, and maximizing the impact of Canadian Science and Technology.
STEMCELL Technologies Inc. is a Canadian biotechnology company that develops specialty cell culture media, cell isolation systems and accessory products for life science research. Driven by science and a passion for quality, STEMCELL supports the advancement of scientific research around the world with our catalogue of more than 2000 cell biology research tools.
Nina Bagri, Associate Director – US Sales Cell Culture Products
– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
The McCarthy Spotlight Speaking Series is one of our longest-standing event series – and one in which our attendees see the most value. Held twice a year, these events are kicked-off with presentations on specific topics by local representatives of LifeSciences BC members. Typically, the event is attended by a cross-section of approximately 40 of our life sciences community members representing mainly industry, NPOs, and Government.
Date: September 22, 2016
4:30 – 5:00 PM – Registration
5:00 – 6:30 PM – Presentations & Panel Discussion
6:30 – 7:30 PM – Wine & Cheese Reception and networking opportunity
For more information, please contact:
Manager, Operations & Events
Tel: 604-669-9909 ext 104